NVAX
NVAX
US6700024010
Novavax, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.123.479.000 682.162.000
64.7%
Cost of Revenue 73.040.000 202.739.000
64.0%
Gross Profit 1.050.439.000 479.423.000
119.1%
499.799.000 728.354.000
31.4%
Operating Income 550.640.000 -248.931.000
321.2%
Pretax Income 442.167.000 -176.615.000
350.4%
Net Income Common Stockholders 440.302.000 -187.499.000
334.8%
-- --
--
-- --
--
ende